World Conference on Lung Cancer
- Health
Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy
Osaka, Japan & Cambridge, Mass., United States: Mobocertinib, an oral targeted therapy, demonstrated clinically meaningful responses, with a confirmed objective…
Read More »